Harvard Apparatus Regen Tech CEO He Junli acquires common shares worth $1.18 million
HRGN•CEO He Junli increased his stake in Harvard Apparatus Regenerative Technology to 1,332,930 common shares. The increase included 683,725 shares from bridge-note conversions and purchases of 361,905 shares at $1.05 and 6,725 shares at $2.15.
1. Stake increase
He Junli, CEO of Harvard Apparatus Regenerative Technology, raised his stake to 1,332,930 common shares. The increase included 683,725 shares received at $1.05 through conversion of bridge notes into common stock, 361,905 shares bought at $1.05 in a private placement and 6,725 shares purchased at $2.15.
